A phase 2 study of eribulin in breast cancer not achieving a pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) Meeting Abstract

Industry Collaboration

cited authors

  • Yardley, D. A., Peacock, N., Shroff, S., Molthrop, D. C., Jr., Anz, B., Daniel, B. R., Young, R. R., Weaver, R., Harwin, W., Webb, C. D., Ward, P., Shastry, M., DeBusk, L. M., Midha, R., Hainsworth, J. D., Burris, H. A., III

Publication Date

  • February 15, 2016

webpage

published in

category

volume

  • 76

WoS Citations

  • 0

WoS References

  • 0